Back
Cerevel Therapeutics Holdings Stock Predictions
Sponsored
CERE
Sponsored
S&P Global: Private Equity Invests $36 Billion Into What?
Read More
Buy
57
CERE
Cerevel Therapeutics Holdings
Last Price:
42.38
Seasonality Move:
-0.49%
7 Day Trial
ALL ACCESS PASS
$
7
Billionaire Investors Join Forces to Fund Next Generation
Learn MoreCerevel Therapeutics Holdings Stock Forecast
- Over the next 52 weeks, Cerevel Therapeutics Holdings has on average historically risen by 47.9% based on the past 3 years of stock performance.
- Cerevel Therapeutics Holdings has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Cerevel Therapeutics Holdings Stock Undervalued?
The current Cerevel Therapeutics Holdings [CERE] share price is $42.34. The Score for CERE is 57, which is 14% above its historic median score of 50, and infers lower risk than normal. - CERE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Cerevel Therapeutics Holdings Stock Go Up Next Year?
- Over the next 52 weeks, Cerevel Therapeutics Holdings has on average historically risen by 47.9% based on the past 3 years of stock performance.
Cerevel Therapeutics Holdings Stock Rating
Buy
57
Cerevel Therapeutics Holdings (CERE)
is a Buy
Is Cerevel Therapeutics Holdings overpriced?
- Cerevel Therapeutics Holdings has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Cerevel Therapeutics Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
cerevel.com
52-Week Data
52-Week High:
43.59
52-Week Low:
19.59
Prediction Charts
Market Cap:
7.69B
Price in USD:
42.34
Volume:
695.41K
Beta:
1.50
Technical Analysis
SMA50:
41.92
SMA100:
38.12
SMA200:
31.86
52-Wk Change:
79.79%
Stock Predictions
-
Is Cerevel Therapeutics Holdings stock public?
Yes, Cerevel Therapeutics Holdings is a publicly traded company. -
What is the Cerevel Therapeutics Holdings stock quote today?
The Cerevel Therapeutics Holdings stock price is 42.34 USD today. -
How to buy Cerevel Therapeutics Holdings stock online?
You can buy Cerevel Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-8 | 41.37 | 41.25 | 41.50 | 41.10 |
Mar-11 | 41.21 | 41.46 | 41.49 | 41.15 |
Mar-12 | 41.33 | 41.88 | 42.05 | 41.33 |
Mar-13 | 41.96 | 42.21 | 42.29 | 41.88 |
Mar-14 | 42.31 | 42.27 | 42.41 | 42.21 |
Mar-15 | 42.20 | 42.33 | 42.42 | 42.17 |
Mar-18 | 42.37 | 42.58 | 42.80 | 42.35 |
Mar-19 | 42.59 | 42.32 | 42.70 | 42.27 |
Mar-20 | 42.30 | 42.31 | 42.49 | 42.24 |
Mar-21 | 42.40 | 42.26 | 42.48 | 42.21 |
Mar-22 | 42.30 | 42.19 | 42.39 | 42.10 |
Mar-25 | 42.20 | 42.40 | 42.45 | 42.20 |
Mar-26 | 42.48 | 42.38 | 42.60 | 42.24 |
Mar-27 | 42.36 | 42.34 | 42.52 | 42.18 |
Cerevel Therapeutics Holdings Earnings
Cerevel Therapeutics Holdings Earnings Report: Per Share Cerevel Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cerevel Therapeutics Holdings Forecast Revenue Growth
Cerevel Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Cerevel Therapeutics Holdings and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.32 per share.
* Cerevel Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.